Yang, D., Xie, Y., Zhao, N., Pan, H., Li, M., & Huang, H. (2015). Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. World J Gastroenterol.
Chicago Style CitationYang, Dan-Hong, Yuan-Jun Xie, Nian-Feng Zhao, Hong-Ying Pan, Ming-Wei Li, and Hai-Jun Huang. "Tenofovir Disoproxil Fumarate Is Superior to Lamivudine Plus Adefovir in Lamivudine-resistant Chronic Hepatitis B Patients." World J Gastroenterol 2015.
MLA CitationYang, Dan-Hong, et al. "Tenofovir Disoproxil Fumarate Is Superior to Lamivudine Plus Adefovir in Lamivudine-resistant Chronic Hepatitis B Patients." World J Gastroenterol 2015.
Warning: These citations may not always be 100% accurate.